Cancer Genetics · 2015 · 36 citations · 18 references
Life SciencesMolecular BiologyOncologyCancer GeneticsGenomicsMolecular OncologyCancer GenomicsCancer Molecular DiagnosticsDna SequencingNext-generation SequencingNext-generation Sequencing In OncologyPolymerase Chain ReactionAssayFormalin-fixed Paraffin-embedded Tissue AnalysisMutation TestingNext-generation Sequencing AssaysParallel SequencingQuantitative Pcr DetectionSingle-nucleotide VariantsTargeted Molecular Therapy
Advances in mutation testing for molecular-targeted cancer therapies have led to the increased use of archived formalin-fixed paraffin-embedded (FFPE) tumors. However, DNA extracted from FFPE tumors (FFPE DNA) is problematic for mutation testing, especially for amplicon-based massively parallel sequencing (MPS), owing to DNA fragmentation and artificial C:G > T:A single nucleotide variants (SNVs) caused by deamination of cytosine to uracil. Therefore, to reduce artificial C:G > T:A SNVs in amplicon-based MPS using FFPE DNA, we evaluated the efficacy of uracil DNA glycosylase (UDG) pretreatment, which can eliminate uracil-containing DNA molecules, with 126 archived FFPE esophageal cancer specimens. We also examined the association between the frequency of C:G > T:A SNVs and DNA quality, as assessed by a quantitative PCR (qPCR)-based assay. UDG pretreatment significantly lowered the frequency of C:G > T:A SNVs in highly fragmented DNA (by approximately 60%). This effect was not observed for good- to moderate-quality DNA, suggesting that a predictive assay (i.e., DNA quality assessment) needs to be performed prior to UDG pretreatment. These results suggest that UDG pretreatment is efficacious for mutation testing by amplicon-based MPS with fragmented DNA from FFPE samples. Advances in mutation testing for molecular-targeted cancer therapies have led to the increased use of archived formalin-fixed paraffin-embedded (FFPE) tumors. However, DNA extracted from FFPE tumors (FFPE DNA) is problematic for mutation testing, especially for amplicon-based massively parallel sequencing (MPS), owing to DNA fragmentation and artificial C:G > T:A single nucleotide variants (SNVs) caused by deamination of cytosine to uracil. Therefore, to reduce artificial C:G > T:A SNVs in amplicon-based MPS using FFPE DNA, we evaluated the efficacy of uracil DNA glycosylase (UDG) pretreatment, which can eliminate uracil-containing DNA molecules, with 126 archived FFPE esophageal cancer specimens. We also examined the association between the frequency of C:G > T:A SNVs and DNA quality, as assessed by a quantitative PCR (qPCR)-based assay. UDG pretreatment significantly lowered the frequency of C:G > T:A SNVs in highly fragmented DNA (by approximately 60%). This effect was not observed for good- to moderate-quality DNA, suggesting that a predictive assay (i.e., DNA quality assessment) needs to be performed prior to UDG pretreatment. These results suggest that UDG pretreatment is efficacious for mutation testing by amplicon-based MPS with fragmented DNA from FFPE samples. Comprehensive genomic studies have revealed genetic variants in oncogenic driver genes involved in human cancers (1Garraway L.A. Lander E.S. Lessons from the cancer genome.Cell. 2013; 153: 17-37Abstract Full Text Full Text PDF PubMed Scopus (914) Google Scholar, 2Alexandrov L.B. Nik-Zainal S. Wedge D.C. et al.Signatures of mutational processes in human cancer.Nature. 2013; 500: 415-421Crossref PubMed Scopus (6272) Google Scholar). These findings have facilitated the development of a classification system of molecular subgroups based on tumor mutation profiles, which is often utilized as a companion diagnostic tool for selecting molecular-targeted therapeutics (3Simon R. Roychowdhury S. Implementing personalized cancer genomics in clinical trials.Nat Rev Drug Discov. 2013; 12: 358-369Crossref PubMed Scopus (237) Google Scholar, 4Arteaga C.L. Baselga J. Impact of genomics on personalized cancer medicine.Clin Cancer Res. 2012; 18: 612-618Crossref PubMed Scopus (48) Google Scholar). As more molecular-targeted therapies are developed, comprehensive genotyping technologies for identifying clinically actionable variants across many genes in a single test with a limited amount of tissue is required (5Spencer D.H. Sehn J.K. Abel H.J. et al.Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.J Mol Diagn. 2013; 15: 623-633Abstract Full Text Full Text PDF PubMed Scopus (145) Google Scholar). Amplicon-based massively parallel sequencing (MPS) with next generation sequencing technology is used for this purpose. This technology includes three amplicon-based methods: targeted capture followed by multiplex PCR, multiplex PCR, and singleplex PCR with digital PCR technologies (6Chang F. Li M.M. Clinical application of amplicon-based next-generation sequencing in cancer.Cancer Genet. 2013; 206: 413-419Abstract Full Text Full Text PDF PubMed Scopus (89) Google Scholar). We previously reported that the TruSeq Amplicon Cancer Panel (TSACP) (Illumina, San Diego, CA) using the targeted capture followed by multiplex PCR method is successful for intact DNA samples extracted from fresh-frozen surgically resected non-small cell lung cancer tissues (7Koh Y. Kenmotsu H. Serizawa M. et al.Identification of actionable mutations in surgically resected tumor specimens from Japanese patients with non-small cell lung cancer by ultra-deep targeted sequencing.J Clin Oncol. 2013; 31 (abstract 7572)Google Scholar). In most diagnostic laboratories, DNA extracted from formalin-fixed and paraffin-embedded (FFPE) tumors (FFPE DNA) is routinely used for mutation testing (8Fairley J.A. Gilmour K. Walsh K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.Curr Drug Targets. 2012; 13: 1475-1487Crossref PubMed Scopus (32) Google Scholar). Moreover, advances in mutation testing for molecular-targeted therapies have led to the increased use of archived FFPE samples in clinical practice (8Fairley J.A. Gilmour K. Walsh K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue.Curr Drug Targets. 2012; 13: 1475-1487Crossref PubMed Scopus (32) Google Scholar, 9Wong S.Q. Li J. Salemi R. et al.Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.Sci Rep. 2013; 3: 3494PubMed Google Scholar). However, FFPE DNA has limitations for mutation testing, including amplicon-based MPS, because formalin fixation, the embedding process, storage conditions, and the duration of storage cause DNA fragmentation and chemical modification of DNA molecules (10Ben-Ezra J. Johnson D.A. Rossi J. et al.Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction.J Histochem Cytochem. 1991; 39: 351-354Crossref PubMed Scopus (320) Google Scholar, 11Williams C. Ponten F. Moberg C. et al.A high frequency of sequence alterations is due to formalin fixation of archival specimens.Am J Pathol. 1999; 155: 1467-1471Abstract Full Text Full Text PDF PubMed Scopus (418) Google Scholar, 12Srinivasan M. Sedmak D. Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids.Am J Pathol. 2002; 161: 1961-1971Abstract Full Text Full Text PDF PubMed Scopus (953) Google Scholar, 13Yokota T. Shibata N. Ura T. et al.Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.Transl Res. 2010; 156: 98-105Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar). Various strategies are used to detect damaged FFPE DNA. To identify DNA samples with acceptable concentrations and lengths for amplicon-based MPS, both DNA quantification with fluorometric detection reagents specific for double-stranded DNA (dsDNA) and quantitative PCR (qPCR)-based assessment for DNA fragmentation have been recognized as effective strategies (9Wong S.Q. Li J. Salemi R. et al.Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.Sci Rep. 2013; 3: 3494PubMed Google Scholar, 14Sedlackova T. Repiska G. Celec P. et al.Fragmentation of DNA affects the accuracy of the DNA quantitation by the commonly used methods.Biol Proced Online. 2013; 15: 5Crossref PubMed Scopus (70) Google Scholar, 15Simbolo M. Gottardi M. Corbo V. et al.DNA qualification workflow for next generation sequencing of histopathological samples.PLoS ONE. 2013; 8: e62692Crossref PubMed Scopus (185) Google Scholar, 16Sah S. Chen L. Houghton J. et al.Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies.Genome Med. 2013; 5: 77Crossref PubMed Scopus (68) Google Scholar). Furthermore, artificial C:G > T:A single nucleotide variants (SNVs), caused by deamination of cytosine to uracil, have significant implications for the accuracy of mutation testing (11Williams C. Ponten F. Moberg C. et al.A high frequency of sequence alterations is due to formalin fixation of archival specimens.Am J Pathol. 1999; 155: 1467-1471Abstract Full Text Full Text PDF PubMed Scopus (418) Google Scholar, 12Srinivasan M. Sedmak D. Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids.Am J Pathol. 2002; 161: 1961-1971Abstract Full Text Full Text PDF PubMed Scopus (953) Google Scholar). C:G > T:A SNVs are the predominant SNV type observed in FFPE DNA (11Williams C. Ponten F. Moberg C. et al.A high frequency of sequence alterations is due to formalin fixation of archival specimens.Am J Pathol. 1999; 155: 1467-1471Abstract Full Text Full Text PDF PubMed Scopus (418) Google Scholar, 17Do H. Dobrovic A. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase.Oncotarget. 2012; 3: 546-558Crossref PubMed Scopus (130) Google Scholar, 18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar), and uracil DNA glycosylase (UDG) pretreatment can effectively reduce their prevalence by degrading uracil-containing DNA molecules (17Do H. Dobrovic A. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase.Oncotarget. 2012; 3: 546-558Crossref PubMed Scopus (130) Google Scholar, 19Hofreiter M. Jaenicke V. Serre D. et al.DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA.Nucleic Acids Res. 2001; 29: 4793-4799Crossref PubMed Scopus (503) Google Scholar). Moreover, the efficacy of UDG pretreatment in amplicon-based MPS with FFPE DNA has been reported by Do et al. (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar) using FFPE DNA extracted from three squamous cell lung cancer tumors, and by Wong et al. (20Wong S.Q. Li J. Tan A.Y. et al.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BMC Med Genomics. 2014; 7: PubMed Scopus Google Scholar) using FFPE DNA extracted from cancer tumors and However, are of sequencing quality accuracy of amplicon-based MPS between and using FFPE DNA from a of Therefore, in this we evaluated the efficacy of UDG pretreatment for amplicon-based MPS with FFPE DNA using 126 archived FFPE esophageal cancer specimens. Moreover, we examined the association between the frequency of artificial C:G > T:A SNVs and DNA quality by with to DNA FFPE tissue samples from patients esophageal cancer and the Cancer of between and fixation and embedding routinely performed with FFPE specimens by to the tumor content for DNA was by both Cancer samples with a of from the paraffin and by with for DNA FFPE tissue was used to genomic DNA from FFPE tumors to the from to DNA (i.e., storage was DNA was using a quantification assay assessment of DNA fragmentation in FFPE DNA was performed using the PCR system of genomic DNA, and the from the FFPE to the by the of the from that of in the three Amplicon-based MPS was performed on the using the which is to detect mutations in genes to the of of genomic DNA was used to the hotspot regions of genes and for of the was with and of samples for sequencing to to the sequencing for samples was performed on with the To more of sequencing with a quality of the used for sequencing was UDG pretreatment was performed as by Do et al. (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar). DNA samples with of UDG for a of of UDG of and of genomic DNA for UDG was for and use in the assay. amount of DNA as that used for in the was used for UDG pretreatment performed on the using sequence the human in the assay are to variants from a sequencing not Therefore, to detection to that of sequencing M. mutation testing in lung for the Cancer Res. 13: PubMed Scopus Google Scholar, R. et al.A PCR sequencing to detect a in colorectal Mol Diagn. 2010; 12: Full Text Full Text PDF PubMed Scopus Google in the the for to samples that sequencing quality was of more with as as by et al. R. et mutational for using for and 2014; PubMed Scopus Google Scholar). This is used for clinical based on the results of R. et mutational for using for and 2014; PubMed Scopus Google Scholar). variants by mutations on the of from Scholar) and the Scholar). mutations from the variants on the of the DNA variants the using the of in Cancer In Scholar), a of variants involved in the variants in the and the variants we on SNVs to the effect of UDG pretreatment on the artificial C:G > T:A SNVs in FFPE DNA in this with the tumor mutation detection was performed to the results in the assay for and performed with San Diego, a significant was performed with We in of esophageal cancer FFPE tissue samples using the assay for quantification DNA fragmentation in FFPE DNA samples was assessed by a and the was as in the and as that is with the of DNA of the for samples was to and approximately of the samples to which is the for for the assay and storage duration is to DNA fragmentation in FFPE DNA (20Wong S.Q. Li J. Tan A.Y. et al.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BMC Med Genomics. 2014; 7: PubMed Scopus Google Scholar), was significant in the storage duration of the FFPE tumors between samples of and This that storage duration not the quality of FFPE DNA used in this FFPE DNA samples tested with the assay to the association between and sequencing assay of FFPE DNA samples samples with for samples These samples from in samples was that samples with of be from the quality from the results of the assay with 126 samples used for and In sequence the samples with of significantly sequence the samples with that of is a to samples that acceptable sequencing we evaluated the association between and of the sequence sequence with and sequencing quality as DNA fragmentation was between DNA and the sequence not that DNA quality, not DNA has a on sequencing These that assessment of DNA fragmentation with a assay can be used to sequencing quality and that is to eliminate quality samples for of sequence between and of pretreatment UDG > > of > based on the results of quality assessment assay using FFPE > > of > based on the results of quality assessment assay using FFPE on targeted regions > > of > based on the results of quality assessment assay using FFPE of > > of > based on the results of quality assessment assay using FFPE > > of > based on the results of quality assessment assay using FFPE in significant of pretreatment UDG of > based on the results of quality assessment assay using FFPE in a between from the assay and from the assessment of DNA sequence including on targeted of and with in and samples. UDG pretreatment increased the of These evaluated using the in significant UDG pretreatment effectively the accuracy of amplicon-based MPS with FFPE DNA because the of C:G > T:A which are the predominant type of artificial SNVs observed in FFPE DNA (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar). in to UDG pretreatment in clinical sequencing with archived FFPE DNA, the effect of UDG pretreatment on sequencing quality in the assay to be We not significant between the treatment for of the sequence for not the samples with of also the samples with These results suggest that are between the from and DNA. However, sequence from samples from samples Moreover, the between and sequence observed in the samples for of in observed in the samples These results that of uracil-containing DNA molecules by UDG pretreatment can and damaged DNA molecules in FFPE DNA and the of the PCR in the in sequencing SNVs with of more and and SNVs in the and These SNVs used in as the association between the sequencing quality in the and the of SNVs in and between and the of SNVs was commonly observed both treatment that the of damaged DNA molecules is with increased for sequencing Moreover, revealed that the of SNVs in the to be that in the for samples with of These by the in the of SNVs with in between the treatment of SNVs in the samples was that in the samples was This between the treatment was to be caused by reduction in the of C:G > T:A SNVs was Therefore, we on of as a to sequencing artifacts that not be and we the prevalence of type of SNV in samples and samples of C:G > T:A SNVs the predominant type of SNVs in both In the prevalence of C:G > T:A SNVs in samples that have of was that of of SNVs in both treatment that the frequency of C:G > T:A artificial SNVs in FFPE DNA was with the of DNA Moreover, reduction in the prevalence of C:G > T:A SNVs because of UDG pretreatment was observed in samples of not in samples These results suggest that UDG pretreatment is effective to reduce the prevalence of C:G > T:A SNVs in fragmented FFPE DNA. Moreover, UDG pretreatment effect on samples that UDG pretreatment is not for samples. Therefore, of be used as a to UDG pretreatment for FFPE DNA is prevalence of type of SNV in samples with and prevalence of the of SNVs in was as pretreatment in in both and and UDG pretreatment in UDG pretreatment approximately reduction in the prevalence of C:G > T:A not in samples with and in damaged DNA with of SNVs to and which is significantly of commonly SNVs in both and samples are more observed the frequency is (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar, S.Q. Li J. Tan A.Y. et al.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BMC Med Genomics. 2014; 7: PubMed Scopus Google Scholar), that SNVs to and Therefore, we performed testing with the to the results in the assay. enables the of C:G > T:A type SNVs from cytosine deamination as variants by sequencing both DNA In C:G > T:A SNV for clinically was also with the and the mutation detection assay and of clinically C:G > T:A SNVs by the with a of in FFPE are in treatment that SNVs frequency of with with frequency of with by with samples mutation detection > > > > > frequency of in samples of is However, this SNV was to a SNV by of > in mutation detection in mutation detection not in in with a of in FFPE are in SNVs with frequency of with by with samples frequency of in samples of is However, this SNV was to a SNV by of in a in mutation detection in mutation detection not in in samples with of SNVs by the of and testing used for the and commonly by in both and samples by the results and SNVs in commonly in both and samples by by both suggesting that the SNVs commonly in both and samples of and of SNVs by in and not by the results suggesting that most of the SNVs by in the and samples the significant reduction in the of from to UDG pretreatment to be clinically SNVs by in SNVs not in the assay the results suggesting a of in the of UDG pretreatment. SNVs in samples with testing that SNVs variants that have been because of the effect of UDG pretreatment of the SNVs in the These results that UDG pretreatment for significant reduction in the of a of variants be As we have UDG pretreatment is effective to cytosine deamination in FFPE DNA. However, > SNVs in are to UDG pretreatment (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar). are and the is to UDG pretreatment on uracil not on (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar). Therefore, we the prevalence of > SNVs and in samples with C:G > SNVs between the and > SNVs for the In samples with and of the samples with C:G > SNVs > SNVs in and suggesting that many C:G > SNVs are not Moreover, a significant reduction of the prevalence of > SNVs was observed on UDG pretreatment for not the and also the in samples with of which significantly by UDG pretreatment This is not with the results reported in a (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar). of > SNVs in samples to that in samples was that of This a for > SNVs the to be to UDG pretreatment. this UDG pretreatment the prevalence of > SNVs caused by cytosine deamination in FFPE DNA and is effective for the limitations of FFPE DNA. In this we examined UDG pretreatment using DNA quality assessment can the limitations of mutation testing with damaged FFPE DNA, as DNA fragmentation and of C:G > T:A artificial SNVs caused by deamination of cytosine to uracil. DNA fragmentation was and was to be significantly with the sequence in the assay and the frequency of sequencing artifacts as C:G > T:A SNVs Therefore, the sequencing quality in the assay. These that of fragmented DNA molecules in FFPE DNA is with the of sequencing Wong et al. (20Wong S.Q. Li J. Tan A.Y. et al.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BMC Med Genomics. 2014; 7: PubMed Scopus Google Scholar) also this association using PCR of DNA and However, not the be used as for the of FFPE DNA, sequencing artifacts as C:G > T:A et al. S. Chen L. Houghton J. et al.Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies.Genome Med. 2013; 5: 77Crossref PubMed Scopus (68) Google Scholar) also reported association between DNA quality and frequency of sequencing artifacts with amplicon-based MPS cancer using a quantitative method based on multiplex the that can be used to identify samples with sequencing artifacts with high S. Chen L. Houghton J. et al.Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies.Genome Med. 2013; 5: 77Crossref PubMed Scopus (68) Google Scholar). DNA quality assessment is commonly used in amplicon-based MPS to high sequencing To this is the most comprehensive of UDG pretreatment for amplicon-based MPS with FFPE DNA to We also the efficacy of UDG pretreatment in C:G > T:A which are the predominant type of sequencing artifacts observed in FFPE results are with of (18Do H. Wong S.Q. Li J. et al.Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.Clin Chem. 2013; 59: 1376-1383Crossref PubMed Scopus (83) Google Scholar, S.Q. Li J. Tan A.Y. et al.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.BMC Med Genomics. 2014; 7: PubMed Scopus Google Scholar). UDG pretreatment effectively the of C:G > T:A especially in samples with of not in samples with that UDG pretreatment is effective for fragmented FFPE DNA. Therefore, in to the of of in the of be also used to UDG pretreatment for FFPE DNA is To this is the to for selecting FFPE DNA that UDG pretreatment. To the of this of the effect of UDG pretreatment on of based on this is prevalence of C:G > T:A SNVs in the samples was high UDG pretreatment with that reported in a using sequencing of intact DNA extracted from surgically resected fresh-frozen esophageal cancer tissues of SNVs frequency of P. S. et and sequencing of esophageal driver and mutational Genet. 2013; PubMed Scopus Google Scholar). are for this because the assay was amplicon-based MPS assay hotspot regions of is that the detection of the assay was that of we used to which be C:G > T:A In the of including not in the prevalence of C:G > T:A SNVs in the FFPE DNA samples was not that in the samples was not which is to that reported previously using sequencing P. S. et and sequencing of esophageal driver and mutational Genet. 2013; PubMed Scopus Google Scholar). These results suggest that UDG pretreatment the sequencing accuracy of the assay with FFPE DNA by the of artificial C:G > T:A SNVs caused by cytosine of the limitations of this is because the fresh-frozen samples from surgically resected tumors used in this not been we not the efficacy of UDG pretreatment by the prevalence of type of SNV in FFPE DNA with that in intact DNA isolated from the samples assessed in this To the efficacy of UDG pretreatment, we to use both fresh-frozen and FFPE samples from the surgically resected tumors in prospective in this we performed testing with the assay and to the results from the assay and a of variants with UDG pretreatment, we to significantly reduce the of caused by cytosine deamination the of UDG pretreatment in damaged DNA. In to this effect of UDG pretreatment, is to the of variants by for the for UDG pretreatment. In this we that the of DNA quality assessment and UDG pretreatment to limitations of FFPE DNA as DNA fragmentation and artificial C:G > T:A SNVs is and This of the sequencing accuracy of the assay with damaged FFPE DNA. Moreover, we that this to the for UDG pretreatment in the assay. Therefore, this be clinical sequencing to personalized cancer based on more accurate mutational from archived FFPE tumors. and and Cancer for is the data to this with with with
18
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov, Serena Nik‐Zainal, David C. Wedge et al. · Nature · 2013 · 10.1K citations · Full text
Medicine, Cancer Biology, Oncology +14
The International HapMap Project
Richard A. Gibbs, John W. Belmont, Paul Hardenbol et al. · Nature · 2003 · 6.2K citations · Full text